OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Consider a matrix of factors when choosing the type of cleanroom facility.
Advanced analytics reveals process insights.
Technology protects the supply chain from manufacturer to patient.
Expert help is crucial for drug sponsors that design their own facilities.
February 24, 2021
The expansion, to be completed in April 2021 aims to increase the CDMO’s viral-vector production capacity in Spain.
Understanding difficulties that can occur during manufacture and resolving them quickly can improve oral solid-dosage drug production.
February 23, 2021
Aprecia's compression-free 3DP manufacturing platform and Glatt’s multiparticulate technologies offer solutions to pharmaceutical dosage design challenges.
February 22, 2021
The second phase of the Myford facility expansion in California will add upstream and downstream processing suites.
February 18, 2021
The deal expands Wavelength’s drug substance manufacturing footprint and its API CDMO business.
Through the agreement, Catalent will manufacture LUPKYNIS (voclosporin), Aurinia’s drug for the treatment of adult patients with lupus nephritis, at its pharmaceutical softgel center of excellence in St. Petersburg, FL.
Cascade began production on new facilities to manufacture APIs for clinical and commercial GMP production.
February 17, 2021
The companies have expanded their existing partnership to include 40 Million Doses of COVID-19 vaccine for South Korea.
The acquisition will integrate drug substance, drug product, and clinical testing capabilities under Quotient.
February 15, 2021
Integration of Brooks Life Sciences BioStore III automated storage and inventory monitoring solution with Cytiva’s Chronicle software will improve traceability, process control, and monitoring capabilities.
Collaboration between equipment suppliers and users is leading to innovation and optimization in biopharmaceutical manufacturing.
Labeling, printing, and on-dose tagging technologies provide a multi-layered approach to anticounterfeiting for pharmaceuticals.
February 11, 2021
Evonik has revealed plans for investment in the short-term expansion of its specialty lipids production, which are used with mRNA-based COVID-19 vaccines.
February 10, 2021
The companies will build capacity in Germany that will be ready in 2022 and are exploring options for increasing volume in 2021.
Lessons learned from the pandemic can advance future biologic drug development and manufacturing.
How can artificial intelligence and machine learning be used to gather and process real-time manufacturing data?
February 04, 2021
The company recently installed a fully validated visual inspection system that uses artificial intelligence in an automated inspection machine.
The CGMP manufacturing agreement will expand production of lenzilumab, a candidate for COVID-19 therapy, to support a potential emergency use authorization filing.
February 03, 2021
As demand for COVID-19 vaccines increases, Big Pharma offers its manufacturing capacity and expertise.
Advanced manufacturing technologies are available, but challenges need to be addressed.